Which Sources of Flavonoids: Complex Diets or Dietary Supplements?

WHO, 2004, The atlas of heart disease and stroke Dauchet, 2006, Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies, J Nutr., 136, 2588, 10.1093/jn/136.10.2588 Nöthlings, 2008, Intake of vegetables, legumes, and fruit, and risk for all-cause, cardiovascular, and cancer mortality in a European diabetic population, J Nutr., 138, 775, 10.1093/jn/138.4.775 He, 2006, Fruit and vegetable consumption and stroke: meta-analysis of cohort studies, Lancet., 367, 320, 10.1016/S0140-6736(06)68069-0 Pascual-Teresa, 2010, Flavanols and anthocyanins in cardiovascular health: a review of current evidence, Int J Mol Sci., 11, 1679, 10.3390/ijms11041679 Pascual-Teresa, 2000, Quantitative analysis of flavan-3-ols in Spanish foodstuffs and beverages, J Agric Food Chem., 48, 5331, 10.1021/jf000549h Hodgson, 2006, Effects of tea and tea flavonoids on endothelial function and blood pressure: a brief review, Clin Exp Pharmacol Physiol., 33, 838, 10.1111/j.1440-1681.2006.04450.x Schewe, 2008, How do dietary flavanols improve vascular function? A position paper, Arch Biochem Biophys., 476, 102, 10.1016/j.abb.2008.03.004 Huxley, 2003, The relation between dietary flavonol intake and coronary heart disease mortality: a meta-analysis of prospective cohort studies, Eur J Clin Nutr., 57, 904, 10.1038/sj.ejcn.1601624 Kessler, 2001, Long-term trends in the use of complementary and alternative medical therapies in the United States, Ann Intern Med., 135, 262, 10.7326/0003-4819-135-4-200108210-00011 Turner, 2004, Effect of circulating forms of soy isoflavones on the oxidation of low density lipoprotein, Free Radic Res., 38, 209, 10.1080/10715760310001641854 Steffen, 2007, Protein modification elicited by oxidized low-density lipoprotein (LDL) in endothelial cells: protection by (-)-epicatechin, Free Radic Biol Med., 42, 955, 10.1016/j.freeradbiomed.2006.12.024 Park, 2000, Activity of monomeric, dimeric, and trimeric flavonoids on NO production, TNF-alpha secretion, and NF-kappaB-dependent gene expression in RAW 264.7 macrophages, FEBS Lett., 465, 93, 10.1016/S0014-5793(99)01735-4 Rimbach, 2000, Macrophages stimulated with IFN-gamma activate NF-kappa B and induce MCP-1 gene expression in primary human endothelial cells, Mol Cell Biol Res Commun., 3, 238, 10.1006/mcbr.2000.0219 Tribolo, 2008, Comparative effects of quercetin and its predominant human metabolites on adhesion molecule expression in activated human vascular endothelial cells, Atherosclerosis., 197, 50, 10.1016/j.atherosclerosis.2007.07.040 Kawai, 2008, Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: implication in the anti-atherosclerotic mechanism of dietary flavonoids, J Biol Chem., 283, 9424, 10.1074/jbc.M706571200 Ishizawa, 2009, Quercetin glucuronide inhibits cell migration and proliferation by platelet-derived growth factor in vascular smooth muscle cells, J Pharmacol Sci., 109, 257, 10.1254/jphs.08236FP Hubbard, 2004, Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans, J Thromb Haemost., 2, 2138, 10.1111/j.1538-7836.2004.01067.x Leikert, 2002, Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells, Circulation., 106, 1614, 10.1161/01.CIR.0000034445.31543.43 Schnorr, 2008, Cocoa flavanols lower vascular arginase activity in human endothelial cells in vitro and in erythrocytes in vivo, Arch Biochem Biophys., 476, 211, 10.1016/j.abb.2008.02.040 Boesch-Saadatmandi, 2010, Impact of apolipoprotein E genotype and dietary quercetin on paraoxonase 1 status in apoE3 and apoE4 transgenic mice, Atherosclerosis., 211, 110, 10.1016/j.atherosclerosis.2010.02.027 Terra, 2009, Grape-seed procyanidins prevent low-grade inflammation by modulating cytokine expression in rats fed a high-fat diet, J Nutr Biochem., 20, 210, 10.1016/j.jnutbio.2008.02.005 Bursill, 2007, A green tea extract lowers plasma cholesterol by inhibiting cholesterol synthesis and upregulating the LDL receptor in the cholesterol-fed rabbit, Atherosclerosis., 193, 86, 10.1016/j.atherosclerosis.2006.08.033 Williamson, 2005, Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies, Am J Clin Nutr., 81, S243, 10.1093/ajcn/81.1.243S Hooper, 2008, Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials, Am J Clin Nutr., 88, 38, 10.1093/ajcn/88.1.38 Garcia-Alonso, 2009, Red wine anthocyanins are rapidly absorbed in humans and affect monocyte chemoattractant protein 1 levels and antioxidant capacity of plasma, J Nutr Biochem., 20, 521, 10.1016/j.jnutbio.2008.05.011 Boesch-Saadatmandi, 2010, Effect of quercetin on paraoxonase 1 activity: studies in cultured cells, mice and humans, J Physiol Pharmacol., 61, 99 Benavente-Garcia, 2008, Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity, J Agric Food Chem., 56, 6185, 10.1021/jf8006568 Rimbach, 2004, Sulfation of genistein alters its antioxidant properties and its effect on platelet aggregation and monocyte and endothelial function, Biochim Biophys Acta, 1670, 229, 10.1016/j.bbagen.2003.12.008 Espin, 2007, Nutraceuticals: facts and fiction, Phytochemistry., 68, 2986, 10.1016/j.phytochem.2007.09.014 Harwood, 2007, A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties, Food Chem Toxicol., 45, 2179, 10.1016/j.fct.2007.05.015 Erdman, 2007, Flavonoids and heart health: proceedings of the ILSI North America Flavonoids Workshop, May 31–June 1, 2005, Washington, DC, J Nutr., 137, S718, 10.1093/jn/137.3.718S Scalbert, 2000, Dietary intake and bioavailability of polyphenols, J Nutr., 130, S2073, 10.1093/jn/130.8.2073S Cermak, 2008, Effect of dietary flavonoids on pathways involved in drug metabolism, Expert Opin Drug Metab Toxicol., 4, 17, 10.1517/17425255.4.1.17 Hider, 2001, Metal chelation of polyphenols, Methods Enzymol., 335, 190, 10.1016/S0076-6879(01)35243-6 Anghileri, 2000, Natural polyphenols-iron interaction: its biological importance, Biol Trace Elem Res., 73, 251, 10.1385/BTER:73:3:251 Ren, 2008, Complexation of flavonoids with iron: structure and optical signatures, J Phys Chem B., 112, 1845, 10.1021/jp076881e Ullmann, 2005, Epigallocatechin gallate (EGCG) (TEAVIGO) does not impair nonhaem-iron absorption in man, Phytomedicine., 12, 410, 10.1016/j.phymed.2004.07.001 Samman, 2001, Green tea or rosemary extract added to foods reduces nonheme-iron absorption, Am J Clin Nutr., 73, 607, 10.1093/ajcn/73.3.607 Ma, 2010, Bioactive dietary polyphenols decrease heme iron absorption by decreasing basolateral iron release in human intestinal Caco-2 cells, J Nutr., 140, 1117, 10.3945/jn.109.117499 Hurrell, 1999, Inhibition of non-haem iron absorption in man by polyphenolic-containing beverages, Br J Nutr., 81, 289, 10.1017/S0007114599000537 Cook, 1995, The effect of red and white wines on nonheme-iron absorption in humans, Am J Clin Nutr., 61, 800, 10.1093/ajcn/61.4.800 Zijp, 2000, Effect of tea and other dietary factors on iron absorption, Crit Rev Food Sci Nutr., 40, 371, 10.1080/10408690091189194 Sandberg, 2002, Bioavailability of minerals in legumes, Br J Nutr., 88, S281, 10.1079/BJN/2002718 Frejnagel, 2010, Comparative effect of green tea, chokeberry and honeysuckle polyphenols on nutrients and mineral absorption and digestibility in rats, Ann Nutr Metab., 56, 163, 10.1159/000278747 Record, 1996, Black tea, green tea, and tea polyphenols. Effects on trace element status in weanling rats, Biol Trace Elem Res., 53, 27, 10.1007/BF02784542 Augustin, 2009, Green tea extracts lower serum folates in rats at very high dietary concentrations only and do not affect plasma folates in a human pilot study, J Physiol Pharmacol., 60, 103 Alemdaroglu, 2007, Inhibition of folic acid uptake by catechins and tea extracts in Caco-2 cells, Planta Med., 73, 27, 10.1055/s-2006-951745 Alemdaroglu, 2008, Influence of green and black tea on folic acid pharmacokinetics in healthy volunteers: potential risk of diminished folic acid bioavailability, Biopharm Drug Dispos., 29, 335, 10.1002/bdd.617 Song, 2002, Flavonoid inhibition of sodium-dependent vitamin C transporter 1 (SVCT1) and glucose transporter isoform 2 (GLUT2), intestinal transporters for vitamin C and glucose, J Biol Chem., 277, 15252, 10.1074/jbc.M110496200 Wiegand, 2010, Dietary flavonoids do not affect vitamin E status in growing rats, J Anim Physiol Anim Nutr (Berl)., 94, 307, 10.1111/j.1439-0396.2008.00910.x Augustin, 2008, Dietary green tea polyphenols do not affect vitamin E status, antioxidant capacity and meat quality of growing pigs, J Anim Physiol Anim Nutr (Berl)., 92, 705, 10.1111/j.1439-0396.2007.00768.x Frank, 2009, Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men, J Nutr., 139, 58, 10.3945/jn.108.096412 Egert, 2008, Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans, J Nutr., 138, 1615, 10.1093/jn/138.9.1615 Ferreira, 2002, Inhibition of thyroid type 1 deiodinase activity by flavonoids, Food Chem Toxicol., 40, 913, 10.1016/S0278-6915(02)00064-9 Chandra, 2010, Goitrogenic/antithyroidal potential of green tea extract in relation to catechin in rats, Food Chem Toxicol., 48, 2304, 10.1016/j.fct.2010.05.064 Milerova, 2006, Actual levels of soy phytoestrogens in children correlate with thyroid laboratory parameters, Clin Chem Lab Med., 44, 171, 10.1515/CCLM.2006.031 Bitto, 2010, Genistein aglycone does not affect thyroid function: results from a three-year, randomized, double-blind, placebo-controlled trial, J Clin Endocrinol Metab., 95, 3067, 10.1210/jc.2009-2779 Doerge, 2002, Goitrogenic and estrogenic activity of soy isoflavones, Environ Health Perspect., 110, 349, 10.1289/ehp.02110s3349 Sacks, 2006, Soy protein, isoflavones, and cardiovascular health: a summary of a statement for professionals from the american heart association nutrition committee, Arterioscler Thromb Vasc Biol., 26, 1689, 10.1161/01.ATV.0000227471.00284.ef Cermak, 2006, The potential of flavonoids to influence drug metabolism and pharmacokinetics by local gastrointestinal mechanisms, Curr Drug Metab., 7, 729, 10.2174/138920006778520570 Alvarez, 2010, Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response, J Pharm Sci., 99, 598, 10.1002/jps.21851 Wojnowski, 2006, Clinical implications of CYP3A polymorphisms, Expert Opin Drug Metab Toxicol., 2, 171, 10.1517/17425255.2.2.171 Rendic, 2002, Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metab Rev., 34, 83, 10.1081/DMR-120001392 Miniscalco, 1992, Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice, J Pharmacol Exp Ther., 261, 1195 Schubert, 1995, Flavonoids in grapefruit juice inhibit the in vitro hepatic metabolism of 17 beta-estradiol, Eur J Drug Metab Pharmacokinet., 20, 219, 10.1007/BF03189673 von Moltke, 2004, Inhibition of human cytochromes P450 by components of Ginkgo biloba, J Pharm Pharmacol., 56, 1039, 10.1211/0022357044021 Tang, 1995, Variable activation of lovastatin by hydrolytic enzymes in human plasma and liver. 4, Eur J Clin Pharmacol., 47, 449, 10.1007/BF00196860 Vree, 2003, Differences between lovastatin and simvastatin hydrolysis in healthy male and female volunteers: gut hydrolysis of lovastatin is twice that of simvastatin, ScientificWorldJournal., 3, 1332, 10.1100/tsw.2003.121 Prueksaritanont, 2003, The human hepatic metabolism of simvastatin hydroxy acid is mediated primarily by CYP3A, and not CYP2D6, Br J Clin Pharmacol., 56, 120, 10.1046/j.1365-2125.2003.01833.x Williams, 2002, Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors, Clin Pharmacokinet., 41, 343, 10.2165/00003088-200241050-00003 Neuvonen, 2006, Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance, Clin Pharmacol Ther., 80, 565, 10.1016/j.clpt.2006.09.003 Cermak, 2009, Effects of the flavonol quercetin on the bioavailability of simvastatin in pigs, Eur J Pharm Sci., 38, 519, 10.1016/j.ejps.2009.09.018 Obermeier, 1995, Effects of bioflavonoids on hepatic P450 activities, Xenobiotica., 25, 575, 10.3109/00498259509061876 Fuhr, 1993, Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man, Br J Clin Pharmacol., 35, 431, 10.1111/j.1365-2125.1993.tb04162.x Tsyrlov, 1994, Isozyme- and species-specific susceptibility of cDNA-expressed CYP1A P-450s to different flavonoids, Biochim Biophys Acta., 1205, 325, 10.1016/0167-4838(94)90252-6 Zhai, 1998, Inhibition of methoxyresorufin demethylase activity by flavonoids in human liver microsomes, Life Sci., 63, PL119, 10.1016/S0024-3205(98)00323-3 Obach, 2000, Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression, J Pharmacol Exp Ther., 294, 88 Aston, 2006, Interaction between warfarin and cranberry juice, Pharmacotherapy., 26, 1314, 10.1592/phco.26.9.1314 Yamazaki, 1997, Human liver cytochrome P450 enzymes involved in the 7-hydroxylation of R- and S-warfarin enantiomers, Biochem Pharmacol., 54, 1195, 10.1016/S0006-2952(97)00304-3 He, 1995, Inhibition of (S)-warfarin metabolism by sulfinpyrazone and its metabolites, Drug Metab Dispos., 23, 659 Greenblatt, 2005, Interaction of warfarin with drugs, natural substances, and foods, J Clin Pharmacol., 45, 127, 10.1177/0091270004271404 Zikria, 2010, Cranberry juice and warfarin: when bad publicity trumps science, Am J Med., 123, 384, 10.1016/j.amjmed.2009.08.019 Kiang, 2005, UDP-glucuronosyltransferases and clinical drug-drug interactions, Pharmacol Ther., 106, 97, 10.1016/j.pharmthera.2004.10.013 Wang, 2006, Inhibition of sulfotransferases by xenobiotics, Curr Drug Metab., 7, 83, 10.2174/138920006774832596 Bosch, 2006, Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer, Clin Pharmacokinet., 45, 253, 10.2165/00003088-200645030-00003 Galijatovic, 2001, Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in Caco-2 cells: potential role in carcinogen bioinactivation, Pharm Res., 18, 374, 10.1023/A:1011019417236 Walle, 2000, Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in the human hepatoma cell line Hep G2, Drug Metab Dispos., 28, 1077 Walle, 2002, Induction of human UDP-glucuronosyltransferase UGT1A1 by flavonoids-structural requirements, Drug Metab Dispos., 30, 564, 10.1124/dmd.30.5.564 Sugatani, 2004, The induction of human UDP-glucuronosyltransferase 1A1 mediated through a distal enhancer module by flavonoids and xenobiotics, Biochem Pharmacol., 67, 989, 10.1016/j.bcp.2003.11.002 van der Logt, 2003, Induction of rat hepatic and intestinal UDP-glucuronosyltransferases by naturally occurring dietary anticarcinogens, Carcinogenesis., 24, 1651, 10.1093/carcin/bgg117 Petri, 2003, Absorption/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum in vivo, Drug Metab Dispos., 31, 805, 10.1124/dmd.31.6.805 Walle, 1995, Quercetin, a potent and specific inhibitor of the human P-form phenosulfotransferase, Biochem Pharmacol., 50, 731, 10.1016/0006-2952(95)00190-B De Santi, 2002, Inhibition of phenol sulfotransferase (SULT1A1) by quercetin in human adult and foetal livers, Xenobiotica., 32, 363, 10.1080/00498250110119108 Marchetti, 2001, Differential inhibition of human liver and duodenum sulphotransferase activities by quercetin, a flavonoid present in vegetables, fruit and wine, Xenobiotica., 31, 841, 10.1080/00498250110069159 Eaton, 1996, Flavonoids, potent inhibitors of the human P-form phenolsulfotransferase. Potential role in drug metabolism and chemoprevention, Drug Metab Dispos., 24, 232 Vietri, 2002, Sulfation of R(-)-apomorphine in the human liver and duodenum, and its inhibition by mefenamic acid, salicylic acid and quercetin, Xenobiotica., 32, 587, 10.1080/00498250210131581 Wiegand, 2009, Effects of quercetin and catechin on hepatic glutathione-S transferase (GST), NAD(P)H quinone oxidoreductase 1 (NQO1), and antioxidant enzyme activity levels in rats, Nutr Cancer., 61, 717, 10.1080/01635580902825621 Morris, 2006, Flavonoid-drug interactions: effects of flavonoids on ABC transporters, Life Sci., 78, 2116, 10.1016/j.lfs.2005.12.003 Brand, 2006, Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients, Biomed Pharmacother., 60, 508, 10.1016/j.biopha.2006.07.081 Ross, 2002, Dietary flavonoids: bioavailability, metabolic effects, and safety, Annu Rev Nutr., 22, 19, 10.1146/annurev.nutr.22.111401.144957 Duthie, 2003, Plant polyphenols: are they the new magic bullet?, Proc Nutr Soc., 62, 599, 10.1079/PNS2003275 Valli, 2002, Benefits, adverse effects and drug interactions of herbal therapies with cardiovascular effects, J Am Coll Cardiol., 39, 1083, 10.1016/S0735-1097(02)01749-7 Poppenga, 2001, Risks associated with the use of herbs and other dietary supplements, Vet Clin North Am Equine Pract., 17, 455, 10.1016/S0749-0739(17)30045-7